ASSOCIATION OF SERUM SCLEROSTIN WITH BONE TURNOVER, ENDOGENOUS HORMONES, BONE MINERAL DENSITY (BMD) AND FRACTURE RISK IN POSTMENOPAUSAL WOMEN: THE OFELY STUDY

被引：0
|
作者：
Garnero, Patrick [1 ,2 ]
Sornay-Rendu, Elisabeth [1 ]
Munoz, Francoise [1 ]
Borel, Olivier [1 ]
Chapurlat, Roland [1 ]
机构：
[1] Univ Lyon, INSERM, Res Unit 1033, Lyon, France
[2] Cisbio Bioassays, Bagnols Sur Ceze, France
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [1] ASSOCIATION OF SERUM SCLEROSTIN WITH BONE TURNOVER, ENDOGENOUS HORMONES, BONE MINERAL DENSITY (BMD) AND FRACTURE RISK IN POSTMENOPAUSAL WOMEN: THE OFELY STUDY
    Garnero, Patrick
    Sornay-Rendu, Elisabeth
    Munoz, Francoise
    Borel, Olivier
    Chapurlat, Roland
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 341 - 341
  • [2] Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study
    Garnero, P.
    Sornay-Rendu, E.
    Munoz, F.
    Borel, O.
    Chapurlat, R. D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (02) : 489 - 494
  • [3] Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study
    P. Garnero
    E. Sornay-Rendu
    F. Munoz
    O. Borel
    R. D. Chapurlat
    [J]. Osteoporosis International, 2013, 24 : 489 - 494
  • [4] Vitamin D status is not associated with bone mineral density, bone turnover, bone loss and fracture risk in postmenopausal women: The Ofely study
    Garnero, P.
    Munoz, F.
    Sornay-Rendu, E.
    Delmas, P. D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S320 - S321
  • [5] Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study
    Garnero, P
    Sornay-Rendu, E
    Claustrat, B
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) : 1526 - 1536
  • [6] Association between sclerostin, serum bone turnover markers and bone density in postmenopausal women with fragility fracture
    Zou, Jian
    Li, Xiaolin
    Yang, Fan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 12984 - 12991
  • [7] Association of Endogenous Hormones and Bone Mineral Density in Postmenopausal Women
    Garcia-Alfaro, Pascual
    Garcia, Sandra
    Rodriguez, Ignacio
    Pascual, Maria Angela
    Perez-Lopez, Faustino R.
    [J]. JOURNAL OF MID-LIFE HEALTH, 2023, 14 (03) : 196 - 204
  • [8] Vitamin D status is not associated with bone mineral density, bone turnover, bone loss and fracture risk in postmenopausal women. The OFELY study
    Garnero, P.
    Munoz, F.
    Sornay-Rendu, E.
    Delmas, P. D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S22 - S22
  • [9] Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study
    Garnero, P.
    Munoz, F.
    Sornay-Rendu, E.
    Delmas, P. D.
    [J]. BONE, 2007, 40 (03) : 716 - 722
  • [10] Bone mineral density (BMD), endogenous hormones, and risk of postmenopausal breast cancer.
    Buist, DSM
    LaCroix, AZ
    Barlow, WE
    White, E
    Cauley, JA
    Bauer, DC
    Weiss, NS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (11) : S31 - S31
12345